Morphotek licenses anti-cancer antibody
This is a discussion on Morphotek licenses anti-cancer antibody within the Biotechnology News forum, part of the Industry News and Updates category; Morphotek has inked a deal with Human Monoclonals International to get rights to a human monoclonal IgM antibody that is ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-06-2008, 03:12 PM
|
|||
|
|||
Morphotek licenses anti-cancer antibody
Morphotek has inked a deal with Human Monoclonals International to get rights to a human monoclonal IgM antibody that is specific to a cancer cell surface antigen. The company hopes to develop a lead Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Boehringer wins approval in anti-clotting drug race | industry_news | Biotechnology News | 0 | 03-27-2008 03:23 PM |
© 2008 DrugManagementForum™ powered by |
 |